title: Critical airway obstruction due to pseudomembranous Aspergillus tracheitis.
authors.affiliation: 1 Department of Pulmonary Medicine and.
authors.forename: Horiana B
authors.initials: HB
authors.lastname: Grosu
authors.forename: Lara
authors.initials: L
authors.lastname: Bashoura
authors.forename: David
authors.initials: D
authors.lastname: Ost
authors.forename: Nelson G
authors.initials: NG
authors.lastname: Ordonez
authors.forename: Saadia A
authors.initials: SA
authors.lastname: Faiz
mesh_terms: D000208:Acute Disease; D000328:Adult; D000402:Airway Obstruction / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001230:Aspergillus / Q000302:isolation & purification; D001999:Bronchoscopy; D017679:Cryotherapy; D004417:Dyspnea / Q000150:complications / Q000209:etiology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy; D009336:Necrosis / Q000382:microbiology / Q000628:therapy; D009503:Neutropenia / Q000188:drug therapy / Q000209:etiology; D013902:Radiography, Thoracic; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use; D014136:Tracheitis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D065819:Voriconazole / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D000935:Antifungal Agents; D000970:Antineoplastic Agents; D013256:Steroids; D065819:Voriconazole